https://de.marketscreener.com/kurs/aktie/FILAMENT-HEALTH-CORP-126523684/news/Filament-Health-gibt-die-Genehmigung-von-Health-Canada-fur-eine-klinische-Phase-2-Studie-mit-dem-bo-45034848/?utm_source=telegram&utm_medium=social&utm_campaign=share